Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
4
Enerpac Tool
EPAC
5
Constellation Brands
STZ
US Stock MarketDetailed Quotes
AKBA Akebia Therapeutics
- 2.450
- +0.000+0.00%
Trading May 15 09:56 ET
643.48MMarket Cap-11.67P/E (TTM)
2.485High2.430Low190.16KVolume2.460Open2.450Pre Close467.67KTurnover0.07%Turnover RatioLossP/E (Static)262.64MShares2.90052wk High26.06P/B629.41MFloat Cap0.80052wk Low--Dividend TTM256.89MShs Float31.000Historical High--Div YieldTTM2.25%Amplitude0.241Historical Low2.459Avg Price1Lot Size
Akebia Therapeutics Key Stats
EPS
According to the latest financial report of Akebia Therapeutics, the latest earnings per share (TTM) for the company is 0.03. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Akebia Therapeutics's free cash flow? The latest report shows it as -13.61M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Akebia Therapeutics shows that the company's current ratio is 2.23, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Akebia Therapeutics, the quick ratio is 1.92, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Akebia Therapeutics? The latest ROE figure is -63.63%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Akebia Therapeutics, the total asset return on investment (ROA) is 2.30%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Akebia Therapeutics's latest financial report to see how their gross margin is doing - currently at 86.70%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Akebia Therapeutics, the net profit margin is 10.66%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025